Full View

Pharmacokinetic– pharmacodynamic analysis of the role of CYP2C19 genotypes in short‐term rabeprazole‐based triple therapy against Helicobacter pylori

JC Yang, YF Yang, YS Uang, CJ Lin… - British journal of …, 2009 - Wiley Online Library
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• Asians have a higher percentage of
CYP2C19 poor metabolizers (PMs) and a high percentage of Helicobacter pylori infection …
被引用次数：20 相关文章
[HTML] nih.gov

[HTML][HTML] Pharmacokinetic–pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori

JC Yang, YF Yang, YS Uang, CJ Lin… - British Journal of Clinical …, 2009 - ncbi.nlm.nih.gov
AIMS The aim was to explore the role of CYP2C19 polymorphism in short-term rabeprazole-
based triple therapy against Helicobacter pylori infection. METHODS Patients with H. pylori …

[引用][C] Pharmacokinetic-pharmacodynamic analysisof the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori

JC YANG, YF YANG, YS UANG… - British journal of …, 2009 - pascal-francis.inist.fr
Pharmacokinetic-pharmacodynamic analysisof the role of CYP2C19 genotypes in short-term
rabeprazole-based triple therapy against Helicobacter pylori CNRS Inist Pascal-Francis CNRS …

Pharmacokinetic–pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori.

JC Yang, YF Yang, YS Uang, CJ Lin… - British Journal of …, 2009 - search.ebscohost.com
Abstract WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• Asians have a higher
percentage of CYP2C19 poor metabolizers (PMs) and a high percentage of Helicobacter …

Pharmacokinetic-pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori

JC Yang, YF Yang, YS Uang, CJ Lin, TH Wang - 2009 - pubmed.ncbi.nlm.nih.gov
Aims The aim was to explore the role of CYP2C19 polymorphism in short-term rabeprazole-
based triple therapy against Helicobacter pylori infection. Methods Patients with H. pylori …

Pharmacokinetic-pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori.

JC Yang, YF Yang, YS Uang, CJ Lin… - British Journal of Clinical …, 2009 - europepmc.org
Aims The aim was to explore the role of CYP2C19 polymorphism in short-term rabeprazole-
based triple therapy against Helicobacter pylori infection. Methods Patients with H. pylori …

Pharmacokinetic-pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori.

JC Yang, YF Yang, YS Uang, CJ Lin… - British Journal of Clinical …, 2009 - europepmc.org
Aims The aim was to explore the role of CYP2C19 polymorphism in short-term rabeprazole-
based triple therapy against Helicobacter pylori infection. Methods Patients with H. pylori …

[引用][C] Pharmacokinetic-pharmacodynamic analysisof the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori

JC YANG, YF YANG, YS UANG, CJ LIN… - British journal of clinical …, 2009 - Blackwell